Antihypertensive Therapy in Dialysed Patients

Vendemia, F; D’Amico, Gianpiero

doi:10.1159/000415247

Cited by 6 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diuretics have an important role in CKD for control of intravascular volume, perhaps as important as ACE inhibitors and ARBs in many patients (40)(41)(42)(43)(44). They have no significant role in ESRD patients, although some prescribe high-dose loop diuretics to limit interdialytic weight gain in patients with modest residual renal function.…”

Section: Hemodialysis Patient Has Predialysis Hypertension That Impromentioning

confidence: 99%

“…Although various techniques are available to determine true dry weight (53), the assessment of blood pressure, commonly used for this purpose at the bedside, is still a matter of clinical judgment and is discussed in detail elsewhere (44,54). There are no reference standards to define a true dry weight.…”

Section: When Should Bilateral Nephrectomy Be Considered In Hypertensmentioning

confidence: 99%

See 1 more Smart Citation

Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice

Nissenson

Agarwal²,

Allon

et al. 2004

Seminars in Dialysis

View full text Add to dashboard Cite

Practicing nephrologists are spending more time caring for end-stage renal disease (ESRD) and chronic kidney disease (CKD) patients. Despite this focus, and considerable advances in the understanding of those aspects of care that impact on clinical outcomes, morbidity, mortality, and quality of life for these patients has not improved substantially over the past decade. One of the possible explanations for this lack of progress is the structure of current nephrology training programs, where ESRD and CKD patient care is not emphasized. To address this issue, we developed a short preceptorship for second-year nephrology fellows, including didactic lectures and workshops. Of 67 participating fellows, 50% were from programs offering 3 or fewer months of exposure to outpatient hemodialysis, and 25% reported no exposure to peritoneal dialysis. Of more concern, 25% reported no "official rounds" with an attending nephrologist on dialysis patients. If nephrologists are to take their appropriate place as leaders of the care delivery team, nephrology fellowships must be restructured with appropriate emphasis placed on the comprehensive care of ESRD and CKD patients.

show abstract

Section: Hemodialysis Patient Has Predialysis Hypertension That Impromentioning

confidence: 99%

Section: When Should Bilateral Nephrectomy Be Considered In Hypertensmentioning

confidence: 99%

Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice

Nissenson

Agarwal²,

Allon

et al. 2004

Seminars in Dialysis

View full text Add to dashboard Cite

show abstract

“…[39] On the other hand, about 75%–80% of patients with ESRD have high blood pressure. [40] In all developed countries and in many developing countries, diabetes and hypertension are considered as the main cause of chronic kidney disease. [23364142434445464748]…”

Section: Introductionmentioning

confidence: 99%

Prevalence of hypertension in renal diseases in Iran: Systematic review and meta-analysis

et al. 2019

View full text Add to dashboard Cite

Background: Hypertension is a risk factor for renal disease. Therefore, this study was aimed at estimating the prevalence of hypertension in renal patients in Iran through meta-analysis. Methods: The search was carried out using authentic Persian and English keywords in national and international databases including IranMedex, SID, Magiran, IranDoc, Medlib, ScienceDirect, Pubmed, Scopus, Cochrane, Embase, Web of Science, Medline, and Google Scholar search engine without any time limitation until 2017. Heterogeneity of studies was assessed using the I 2 index. Data were analyzed using STATA ver 11. Results: In 35 reviewed studies with a sample of 39,621 subjects, the prevalence of hypertension in renal patients was 35% (95% CI: 29%–41%) (25% in women and 18% in men). The prevalence of systolic hypertension in renal patients was 5%, diastolic hypertension 26%, and diabetes 23%. The prevalence of hypertension in hemodialysis patients was 34%, 27% in peritoneal dialysis, 43% in kidney transplantation, and 26% in chronic renal failure. In addition, meta-regression showed that the prevalence of hypertension in renal patients did not significantly decrease during the years 1988–2017. Conclusions: More than a third of kidney patients in Iran suffer from high blood pressure. The diastolic blood pressure of these patients is about five times higher than their systolic blood pressure. Moreover, the age group under 30 is a high-risk group. The prevalence of hypertension in women with kidney disease is higher than in men. In addition, patients who have kidney transplants are more likely to have high blood pressure than other kidney patients.

show abstract

Therapy of Hypertension in End-Stage Renal Disease

Roy¹,

Leenen²

1992

Cardiac Dysfunction in Chronic Uremia

View full text Add to dashboard Cite

Antihypertensive Therapy in Dialysed Patients

Cited by 6 publications

References 0 publications

Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice

Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice

Prevalence of hypertension in renal diseases in Iran: Systematic review and meta-analysis

Therapy of Hypertension in End-Stage Renal Disease

Contact Info

Product

Resources

About